Biological Mechanisms Linking Alzheimer's Disease and Type-2 Diabetes Mellitus

被引:30
作者
Mushtaq, Gohar [1 ]
Khan, Jalaluddin A. [1 ]
Kamal, Mohammad A. [2 ]
机构
[1] King Abdulaziz Univ, Coll Sci, Dept Biochem, Jeddah 21589, Saudi Arabia
[2] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia
关键词
Alzheimer's disease; beta-amyloid; cognitive impairment; dementia; hyperinsulinemia; impaired glucose metabolism; insulin resistance; neurofibrillary tangles; oxidative stress; type 2 diabetes mellitus; GLYCATION END-PRODUCTS; AMYLOID PRECURSOR PROTEIN; INSULIN-DEGRADING ENZYME; CARDIOVASCULAR RISK-FACTORS; GLYCOGEN-SYNTHASE KINASE-3; MILD COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; APOLIPOPROTEIN-E; IMMUNOHISTOCHEMICAL LOCALIZATION; GLUCOSE TRANSPORTERS;
D O I
10.2174/1871527313666140917114537
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The emerging data suggest that type 2 diabetes mellitus (T2DM) can contribute significantly to the onset or progression of Alzheimer's disease (AD) either directly or as a cofactor. Various in vitro and in vivo animal and human clinical studies have provided evidence that T2DM is a major risk factor in the pathology of AD and the two diseases share common biological mechanisms at the molecular level. The biological mechanisms that are common in the pathology of both T2DM and AD include insulin resistance, impaired glucose metabolism, beta-amyloid formation, oxidative stress, and the presence of advanced glycation end products. With better understanding of the degree of association between AD and T2DM and the underlying molecular mechanisms explaining this relationship, it is hoped that researchers will be able to develop effective therapeutic interventions to treat or control T2DM and, as a consequence, delay the onset or progression of AD.
引用
收藏
页码:1192 / 1201
页数:10
相关论文
共 120 条
[1]   Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease [J].
Aliev, G. ;
Priyadarshini, M. ;
Reddy, V. P. ;
Grieg, N. H. ;
Kaminsky, Y. ;
Cacabelos, R. ;
Ashraf, G. Md ;
Jabir, N. R. ;
Kamal, M. A. ;
Nikolenko, V. N. ;
Zamyatnin, A. A., Jr. ;
Benberin, V. V. ;
Bachurin, S. O. .
CURRENT MEDICINAL CHEMISTRY, 2014, 21 (19) :2208-2217
[2]  
Alzheimer's Association 2010, 2010, ALZH ASS 2010 ALZH D
[3]  
[Anonymous], 2009, ALZHEIMERS DEMENT, DOI DOI 10.1016/J.JALZ.2009.04.287
[4]  
[Anonymous], AM J NEUROPROT NEURO
[5]   Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats [J].
Aragno, M ;
Brignardello, E ;
Tamagno, E ;
Gatto, V ;
Danni, O ;
Boccuzzi, G .
JOURNAL OF ENDOCRINOLOGY, 1997, 155 (02) :233-240
[6]   CHANGES IN ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE IN ALZHEIMERS-DISEASE RESEMBLE EMBRYONIC-DEVELOPMENT - A STUDY OF MOLECULAR-FORMS [J].
ARENDT, T ;
BRUCKNER, MK ;
LANGE, M ;
BIGL, V .
NEUROCHEMISTRY INTERNATIONAL, 1992, 21 (03) :381-396
[7]   Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function [J].
Arvanitakis, Z ;
Wilson, RS ;
Bienias, JL ;
Evans, DA ;
Bennett, DA .
ARCHIVES OF NEUROLOGY, 2004, 61 (05) :661-666
[8]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[9]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[10]   HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, JB ;
LESLEY, R ;
SCHUBERT, D .
CELL, 1994, 77 (06) :817-827